26.05.2015 08:00

Oslo, Norway, 26 May 2015:Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces that its market maker agreement with DNB Markets will be replaced with a similar market maker agreement with Norne Securities with effect as of 1 August 2015.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000, Email: ed@photocure.no

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)





This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Photocure ASA via Globenewswire

HUG#1923559

distributed by